These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Ros PR; Freeny PC; Harms SE; Seltzer SE; Davis PL; Chan TW; Stillman AE; Muroff LR; Runge VM; Nissenbaum MA Radiology; 1995 Aug; 196(2):481-8. PubMed ID: 7617864 [TBL] [Abstract][Full Text] [Related]
18. Differentiating focal eosinophilic liver disease from hepatic metastases using unenhanced and gadoxetic acid-enhanced MRI. Kim YK; Lee YH; Kim CS; Lee MW Abdom Imaging; 2011 Aug; 36(4):425-32. PubMed ID: 21748468 [TBL] [Abstract][Full Text] [Related]
19. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092 [TBL] [Abstract][Full Text] [Related]
20. [The integrated diagnosis of hepatic focal nodular hyperplasia: echography, color Doppler, computed tomography and magnetic resonance compared]. De Gaetano A; De Franco A; Maresca G; Manfredi R; Barbaro B; Monteforte MG Radiol Med; 1996 Mar; 91(3):258-69. PubMed ID: 8628940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]